Details for New Drug Application (NDA): 214790
✉ Email this page to a colleague
NDA 214790 describes SERTRALINE HYDROCHLORIDE, which is a drug marketed by Almatica, Aurobindo Pharma, Ranbaxy Labs Ltd, Strides Pharma, Accord Hlthcare, Anda Repository, Appco, Ascent Pharms Inc, Chartwell Molecular, Granules, Heritage Pharma Avet, Hikma Pharms, Invagen Pharms, Ivax Sub Teva Pharms, Lupin, Mylan Pharms Inc, Norvium Bioscience, Oxford Pharms, Reyoung, Sciegen Pharms Inc, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Torrent Pharms, Viwit Pharm, and Zydus, and is included in thirty-one NDAs. It is available from forty-two suppliers. Additional details are available on the SERTRALINE HYDROCHLORIDE profile page.
The generic ingredient in SERTRALINE HYDROCHLORIDE is sertraline hydrochloride. There are twenty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the sertraline hydrochloride profile page.
The generic ingredient in SERTRALINE HYDROCHLORIDE is sertraline hydrochloride. There are twenty-two drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the sertraline hydrochloride profile page.
Summary for 214790
| Tradename: | SERTRALINE HYDROCHLORIDE |
| Applicant: | Ascent Pharms Inc |
| Ingredient: | sertraline hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 214790
| Mechanism of Action | Cytochrome P450 2D6 Inhibitors Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 214790
Suppliers and Packaging for NDA: 214790
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 214790 | ANDA | Camber Pharmaceuticals, Inc. | 31722-145 | 31722-145-05 | 500 TABLET in 1 BOTTLE (31722-145-05) |
| SERTRALINE HYDROCHLORIDE | sertraline hydrochloride | TABLET;ORAL | 214790 | ANDA | Camber Pharmaceuticals, Inc. | 31722-145 | 31722-145-30 | 30 TABLET in 1 BOTTLE (31722-145-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
| Approval Date: | May 3, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
| Approval Date: | May 3, 2021 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | May 3, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
